/
Pipeline Programs↗
Active Trials↗
Companies Involved↗
Squamous Non-small-cell Lung Cancer is an early-stage landscape with 5 programs across 4 companies. The most active players are Sichuan Baili Pharmaceutical Co., Ltd., Alentis Therapeutics AG.
Intelligence
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Bubble size = clinical trials
Key Players
Pipeline
Analysis
2
clinical trials
Clinical Trials
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)